Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: A population-based analysis

British Journal of Haematology

Volumn 163, Issue 1, 2013, Pages 40-46

  Pozzi, Samantha ^a   Marcheselli, Luigi ^a,b   Bari, Alessia ^a   Liardo, Eliana V ^a   Marcheselli, Raffaella ^a   Luminari, Stefano ^a   Quaresima, Micol ^a   Cirilli, Claudia ^b   Ferri, Paola ^a   Federico, Massimo ^a,b   Sacchi, Stefano ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b MODENA CANCER REGISTRY   (Italy)

Author keywords

Epidemiology; Multiple myeloma; Population study; Survival; Therapy

Indexed keywords

MELPHALAN;

AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; RELATIVE SURVIVAL; SURVIVAL; TREATMENT RESPONSE;

EPIDEMIOLOGY; MULTIPLE MYELOMA; POPULATION STUDY; SURVIVAL; THERAPY;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; POPULATION SURVEILLANCE; REGISTRIES;

EID: 84884137902     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12465     Document Type: Article

References (15)

1. Campagnaro, E.L., Jacobus, S.J., Uno, H., Oken, M.M., Kyle, R.A., Rajkumar, S.V., Greipp, P.R., Vesole, D.H., Weiss, M., Fonseca, R. & Lazarus, H.M. (2011) Survival outcomes in elderly patients with plasma cell myeloma: the three-decade Eastern Cooperative Oncology Group (ECOG) experience. Journal of Clinical Oncology, ASCO Annual Meeting Proceedings (Post-Meeting Edition), 29, No 15_suppl, 2011: ab. 8021.
2. Cox, D. (1972) Regression models and life tables. Journal of the Royal Statistical Society. Series B (Methodological), 34, 187-202.
3. Dickman, P.W., Sloggett, A., Hills, M. & Hakulinen, T. (2004) Regression models for relative survival. Statistics in Medicine, 23, 51-64.
4. Ederer, F. & Heise, H. (1959) Instructions to IBM 650 programmers in processing survival computations. Methodological note no. 10. End Results Evaluation Section, National Cancer Institute, Bethesda, MD, USA.
5. Greenlee, R.T., Murray, T., Bolden, S. & Wingo, P.A. (2000) Cancer statistics, 2000. CA: A Cancer Journal for Clinician, 50, 7-33.
6. Greipp, P.R., San Miguel, J., Durie, B.G., Crowley, J.J., Barlogie, B., Bladé, J., Boccadoro, M., Child, J.A., Avet-Loiseau, H., Kyle, R.A., Lahuerta, J.J., Ludwig, H., Morgan, G., Powles, R., Shimizu, K., Shustik, C., Sonneveld, P., Tosi, P., Turesson, I. & Westin, J. (2005) International staging system for multiple myeloma. Journal of Clinical Oncology, 23, 3412-3420.
7. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T. & Thun, M.J. (2008) Cancer statistics, 2008. CA: A Cancer Journal for Clinician, 58, 71-96.
8. Kristinsson, S.Y., Landgren, O., Dickman, P.W., Derolf, Å.R. & Björkholm, M. (2007) Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. Journal of Clinical Oncology, 25, 1993-1999.
9. Kumar, S.K., Rajkumar, S.V., Dispenzieri, A., Lacy, M.Q., Hayman, S.R., Buadi, F.K., Zeldenrust, S.R., Dingli, D., Russell, S.J., Lust, J.A., Greipp, P.R., Kyle, R.A. & Gertz, M.A. (2008) Improved survival in multiple myeloma and the impact of novel therapies. Blood, 111, 2516-2520.
10. Kumar, S.K., Dispenzieri, A., Gertz, M.A., Lacy, M.Q., Lust, J.A., Hayman, S.R., Buadi, F.K., Dingli, D., Zeldenrust, S.R., Russell, S., Kapoor, P., Lin, Y., Hwa, L., Larson, D., Colby, C.L., Benson, J.T., Kyle, R.A. & Rajkumar, S.V. (2012) Continued improvement in survival in multiple myeloma and the impact of novel agents. Blood (ASH Annual Meeting abstracts), 120, 3972.
11. Ludwig, H., Durie, B.M.G., Bolejack, V., Turesson, I., Kyle, R.A., Blade, J., Fonseca, R., Dimopoulos, M., Shimizu, K., San Miguel, J., Westin, J., Harousseau, J.L., Beksac, M., Boccadoro, M., Palumbo, A., Barlogie, B., Shustik, C., Cavo, M., Greipp, P.R., Joshua, D., Attal, M., Sonneveld, P. & Crowley, J. (2008) Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group. Blood, 111, 4039-4047.
12. Palumbo, A. & Anderson, K. (2011) Multiple myeloma. The New England Journal of Medicine, 364, 1046-1060.
13. Siegel, R., Ward, E., Brawley, O. & Jemal, A. (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: A Cancer Journal for Clinician, 61, 212-236.
14. Turesson, I., Velez, R., Kristinsson, S.Y. & Landgren, O. (2010) Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. Journal of Clinical Oncology, 10, 830-834.
15. Wu, Y.X., Tekkenberg, J.J.M. & Grunkemeier, G.L. (2008) Measuring follow-up completeness. The Annals of Thoracic Surgery, 85, 1155-1157.